| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |